Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Up 81.0% in September

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 18,100 shares, a growth of 81.0% from the September 15th total of 10,000 shares. Based on an average trading volume of 22,400 shares, the days-to-cover ratio is presently 0.8 days.

Tema Cardiovascular and Metabolics ETF Trading Up 1.9 %

Shares of NASDAQ:HRTS opened at $33.83 on Friday. The stock has a market capitalization of $83.90 million, a PE ratio of 32.89 and a beta of 0.93. Tema Cardiovascular and Metabolics ETF has a 1 year low of $26.26 and a 1 year high of $36.03. The firm has a fifty day moving average price of $34.05 and a 200 day moving average price of $33.31.

Institutional Trading of Tema Cardiovascular and Metabolics ETF

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. increased its position in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 20.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 153,090 shares of the company’s stock after buying an additional 26,130 shares during the period. Tema Cardiovascular and Metabolics ETF accounts for approximately 1.4% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 20th biggest position. Sterling Investment Advisors Ltd. owned about 6.03% of Tema Cardiovascular and Metabolics ETF worth $5,104,000 at the end of the most recent reporting period.

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.